Ventas Inc (VTR) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
Ventas Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period
Return on Investment, Quarterly Results, Trends, Rankings, Statistics
What is Ventas Inc's ROI in the second quarter of 2026? Ventas inc achieved a return on average invested assets (ROI) of 0.91 % in its second quarter of 2026, which is below Ventas Inc's average return on investment, which stands at 2.53%.
ROI fell compared to the first quarter of 2026, despite the net income growth of 22.31% from the first quarter of 2026.
Within the Financial sector 611 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1922 to 2334.
Ventas Awarded Prestigious Nareit 2024 Healthcare Leader in the Light Award Chicago-based Ventas, Inc. (NYSE: VTR) has once again been recognized for its exceptional commitment to sustainability, earning the 2024 Nareit Leader in the Light award for the Healthcare sector. This accolade, awarded by the National Association of Real Estate Investment Trusts (Nareit), acknowledges Ventas s superior and consistent sustainability practices. Notably, this marks the eighth occasion Ventas has received this prestigious recognition, underscoring the company s dedication and leadership in sustainable real estate practices.In addition to the Leader in the Light award, Ventas has been honored with Nareit s inaugural Impact at Scale award. This new recognition highlights the company s innovative and scalable approach to decarbonization, aligning with global efforts to reduce carbon emissions and combat climate change. As part of this commitment, Ventas is implementing strategies and technologies designed to achieve its sustainability goals, which include reducing carbon footprint and promoting energy efficiency across its healthcare real estate portfolio.
In a strategic move to enhance its governance and support ongoing development, Ventas, Inc. (NYSE: VTR), a leading healthcare real estate company, has announced the appointment of Theodore Bigman and Joe V. Rodriguez, Jr. to its Board of Directors. The appointments come as part of Ventas commitment to Board refreshment and maintaining robust governance. Additionally, the company has entered into a mutual cooperation agreement with shareholder Land and Buildings Investment Management LLC (Land and Buildings) to further align its objectives with stakeholder interests.
Ventas, Inc. has witnessed challenging times in the recent past, recording a cumulative net loss of $30 million during the 12-month period ending in the fourth quarter of 2023. Consequently, the company experienced a negative return on investment (ROI) of -0.12%. While Ventas ROI lags behind 79 other companies within the Financial sector, it is important to note that the overall ranking in terms of ROI has improved from 2501 in the third quarter of 2023 to 500 in the fourth quarter, indicating progressive performance.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
